The global cancer vaccines market, valued at US$10.23 billion in 2023, is forecasted to grow at a robust CAGR of 8.6%, ...

Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...

A new report revealed a troubling shift in cancer demographics, with women and younger people now bearing a larger brunt of ...

Russia claims a breakthrough in cancer treatment with a personalized mRNA vaccine, designed to train the immune system to ...

A growing array of pharmaceutical options has investigators trying to figure out which drugs and drug combinations are the ...

Researchers shed light on the genes that could be linked to the high mortality rates of prostate cancer among men of African ...

The American Cancer Society projected approximately 2 million new cancer diagnoses and 618,000 new cancer deaths in the U.S.

Russia has reportedly developed a vaccine against cancer that it will launch early next year. The jab, which will be free of ...

However, apart from Sipuleucel-T for metastatic prostate cancer patients, none of them has been found to be successful in treating cancer patients. The development of cancer vaccines for other ...

Preclinical studies have demonstrated that vaccines targeting prostate and prostate cancer-associated antigens can induce immune responses to those antigens and result in protection from ...

First Commercial mRNA Vaccine Approval Expected By 2029 Says Kuick Research. Delhi, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Global ...

Given the high cancer burden in Nigeria, the Nigerian Cancer Society,NCS, has appealed to the federal government to raise the ...